Michael Scolaro

Michael Scolaro

Oct 18, 2017

Group 6 Copy 31
0
    Please wait...

    About This Project

    We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

    Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Can cockroaches help us cure tularemia?

    Tularemia is a deadly disease caused by the bacterium Francisella tularensis (Ft). This bacterium is also a...

    Which Human Physical Aging Biomarkers Validate Genetic and Biochemical Aging Reversal Success?

    Harvard Medical School has reported successful aging reversal using genetic and biochemical methods in the labs...

    Next Generation Non-Seeing Eye Prosthesis

    This project aims to push the current state of the art in ocular prothestics by integrating a small system of...

    Backer Badge Funded